BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cowden JM, Yu F, Banie H, Farahani M, Ling P, Nguyen S, Riley JP, Zhang M, Zhu J, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis 2014;73:600-8. [PMID: 24126456 DOI: 10.1136/annrheumdis-2013-203832] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Thurmond RL. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol 2015;6:65. [PMID: 25873897 DOI: 10.3389/fphar.2015.00065] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
2 Boyle DL, Deprimo SE, Calderon C, Chen D, Dunford PJ, Barchuk W, Firestein GS, Thurmond RL. Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study. Inflamm Res 2019;68:261-74. [DOI: 10.1007/s00011-019-01218-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL. Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 2014;349:176-84. [PMID: 24549371 DOI: 10.1124/jpet.113.211714] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
4 Wunschel EJ, Schirmer B, Seifert R, Neumann D. Lack of Histamine H4-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice. Front Pharmacol 2017;8:642. [PMID: 28955241 DOI: 10.3389/fphar.2017.00642] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
5 Buckland J. Experimental arthritis: Antihistamines as treatments for autoimmune disease? Nat Rev Rheumatol 2013;9:696. [PMID: 24166240 DOI: 10.1038/nrrheum.2013.169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Schirmer B, Rother T, Bruesch I, Bleich A, Werlein C, Jonigk D, Seifert R, Neumann D. Genetic Deficiency of the Histamine H4-Receptor Reduces Experimental Colorectal Carcinogenesis in Mice. Cancers (Basel) 2020;12:E912. [PMID: 32276475 DOI: 10.3390/cancers12040912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Toya M, Akasaki Y, Sueishi T, Kurakazu I, Kuwahara M, Uchida T, Tsutsui T, Tsushima H, Yamada H, Lotz MK, Nakashima Y. G protein-coupled receptor kinase 5 deletion suppresses synovial inflammation in a murine model of collagen antibody-induced arthritis. Sci Rep 2021;11:10481. [PMID: 34006987 DOI: 10.1038/s41598-021-90020-0] [Reference Citation Analysis]
8 Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou CF, Kato T, Guzzo C, Thurmond RL, Ohtsuki M, Furue M. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J Dermatol 2015;42:129-39. [PMID: 25491792 DOI: 10.1111/1346-8138.12726] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
9 Kay LJ, Suvarna SK, Peachell PT. Histamine H4 receptor mediates chemotaxis of human lung mast cells. Eur J Pharmacol 2018;837:38-44. [PMID: 30148998 DOI: 10.1016/j.ejphar.2018.08.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Schirmer B, Rezniczek T, Seifert R, Neumann D. Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis. Biochem Pharmacol 2015;98:102-9. [PMID: 26365468 DOI: 10.1016/j.bcp.2015.09.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
11 Kiss R, Keseru GM. Novel histamine H 4 receptor ligands and their potential therapeutic applications: an update. Expert Opinion on Therapeutic Patents 2014;24:1185-97. [DOI: 10.1517/13543776.2014.959494] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
12 Savall BM, Chavez F, Tays K, Dunford PJ, Cowden JM, Hack MD, Wolin RL, Thurmond RL, Edwards JP. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists. J Med Chem 2014;57:2429-39. [PMID: 24495018 DOI: 10.1021/jm401727m] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
13 Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Al-Mazroua HA, Khan MR, Alasmari AF, Alanazi WA, As Sobeai HM, Attia SM. The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T+ Itpr3tf/J mice exposed to gamma rays. Mol Immunol 2019;114:561-70. [PMID: 31522074 DOI: 10.1016/j.molimm.2019.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Smolinska S, Groeger D, Perez NR, Schiavi E, Ferstl R, Frei R, Konieczna P, Akdis CA, Jutel M, Oʼmahony L. Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2016;22:1575-86. [DOI: 10.1097/mib.0000000000000825] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
15 Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP. Clinical Development of Histamine H4 Receptor Antagonists. Handb Exp Pharmacol 2017;241:301-20. [PMID: 28233185 DOI: 10.1007/164_2016_130] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
16 Ehling S, Roßbach K, Dunston SM, Stark H, Bäumer W. Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo. J Dermatol Sci 2016;83:106-15. [PMID: 27155791 DOI: 10.1016/j.jdermsci.2016.04.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
17 Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev 2015;67:601-55. [PMID: 26084539 DOI: 10.1124/pr.114.010249] [Cited by in Crossref: 263] [Cited by in F6Publishing: 240] [Article Influence: 43.8] [Reference Citation Analysis]
18 Anoush M, Mohammad Khani MR. Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats. Adv Pharm Bull 2015;5:217-22. [PMID: 26236660 DOI: 10.15171/apb.2015.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
19 Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS. Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies. J Rheumatol 2016;43:1637-42. [DOI: 10.3899/jrheum.160164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kim M, Choe Y, Lee H, Jeon MG, Park JH, Noh HS, Cheon YH, Park HJ, Park J, Shin SJ, Lee K, Lee SI. Blockade of translationally controlled tumor protein attenuated the aggressiveness of fibroblast-like synoviocytes and ameliorated collagen-induced arthritis. Exp Mol Med 2021;53:67-80. [PMID: 33408335 DOI: 10.1038/s12276-020-00546-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kim KW, Kim BM, Lee KA, Lee SH, Firestein GS, Kim HR. Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis. Sci Rep 2017;7:1197. [PMID: 28446753 DOI: 10.1038/s41598-017-01101-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
22 Lichterman JN, Reddy SM. Mast Cells: A New Frontier for Cancer Immunotherapy. Cells 2021;10:1270. [PMID: 34063789 DOI: 10.3390/cells10061270] [Reference Citation Analysis]
23 Moriguchi T, Takai J. Histamine and histidine decarboxylase: Immunomodulatory functions and regulatory mechanisms. Genes Cells 2020;25:443-9. [PMID: 32394600 DOI: 10.1111/gtc.12774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Capelo R, Lehmann C, Ahmad K, Snodgrass R, Diehl O, Ringleb J, Flamand N, Weigert A, Stark H, Steinhilber D, Kahnt AS. Cellular analysis of the histamine H4 receptor in human myeloid cells. Biochem Pharmacol 2016;103:74-84. [PMID: 26774453 DOI: 10.1016/j.bcp.2016.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
25 Albrecht M, Dittrich AM. Expression and function of histamine and its receptors in atopic dermatitis. Mol Cell Pediatr 2015;2:16. [PMID: 26690068 DOI: 10.1186/s40348-015-0027-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
26 Moret FM, Radstake TR, van Roon JA. Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies? Ann Rheum Dis 2014;73:477-9. [PMID: 24323396 DOI: 10.1136/annrheumdis-2013-204285] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Shan Y, Gao Y, Zhang L, Ma L, Shi Y, Liu X. H4 Receptor Inhibits Lipopolysaccharide-induced NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor-Associated Factor 6. Neuroscience 2019;398:113-25. [PMID: 30528857 DOI: 10.1016/j.neuroscience.2018.11.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Thangam EB, Jemima EA, Singh H, Baig MS, Khan M, Mathias CB, Church MK, Saluja R. The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets. Front Immunol 2018;9:1873. [PMID: 30150993 DOI: 10.3389/fimmu.2018.01873] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 23.0] [Reference Citation Analysis]
29 Singh M, Singh V, Schurman JV, Friesen CA. Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis. Dig Dis Sci 2020;65:3184-90. [PMID: 31916087 DOI: 10.1007/s10620-019-06041-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ohtsu H, Seike M. Histamine and Histamine Receptors in Allergic Dermatitis. Handb Exp Pharmacol 2017;241:333-45. [PMID: 27787718 DOI: 10.1007/164_2016_9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
31 Tatarkiewicz J, Rzodkiewicz P, Żochowska M, Staniszewska A, Bujalska-Zadrożny M. New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders. Arch Med Sci 2019;15:537-53. [PMID: 30899308 DOI: 10.5114/aoms.2017.68534] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kim CH, Lee JM, Yoo JK, Kim JS, Kim SU, Chang KT, Choo YK. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine. Scand J Immunol 2016;83:409-17. [PMID: 26900758 DOI: 10.1111/sji.12420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
33 Alkan M, Machavoine F, Rignault R, Dam J, Dy M, Thieblemont N. Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice. J Diabetes Res 2015;2015:965056. [PMID: 26090474 DOI: 10.1155/2015/965056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mehta P, Miszta P, Rzodkiewicz P, Michalak O, Krzeczyński P, Filipek S. Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases. Life (Basel) 2020;10:E50. [PMID: 32344736 DOI: 10.3390/life10040050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
35 Hirasawa N. Expression of Histidine Decarboxylase and Its Roles in Inflammation. Int J Mol Sci 2019;20:E376. [PMID: 30654600 DOI: 10.3390/ijms20020376] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
36 Bein K, Ganguly K, Martin TM, Concel VJ, Brant KA, Di YPP, Upadhyay S, Fabisiak JP, Vuga LJ, Kaminski N, Kostem E, Eskin E, Prows DR, Jang AS, Leikauf GD. Genetic determinants of ammonia-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2021;320:L41-62. [PMID: 33050709 DOI: 10.1152/ajplung.00276.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Nagarajan G, Mariappanadar V, Tamizh M, Kaliappan I, Elden BT. Effect of H4R antagonist N -(2-aminoethyl)-5-chloro-1 H -indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1 H -benzimidazole on histamine and 4-methylhistamine-induced mast cell response. Journal of Receptors and Signal Transduction 2017;37:304-13. [DOI: 10.1080/10799893.2016.1247863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Kyriakidis K, Zampeli E, Palaiologou M, Tiniakos D, Tiligada E. Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo. Inflammation 2015;38:949-58. [PMID: 25359709 DOI: 10.1007/s10753-014-0057-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Geyer R, Nordemann U, Strasser A, Wittmann HJ, Buschauer A. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists. J Med Chem 2016;59:3452-70. [PMID: 27007611 DOI: 10.1021/acs.jmedchem.6b00120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Schirmer B, Neumann D. The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut. Int J Mol Sci 2021;22:6116. [PMID: 34204101 DOI: 10.3390/ijms22116116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Tang KT, Chao YH, Chen DY, Lim YP, Chen YM, Li YR, Yang DH, Lin CC. Betahistine attenuates murine collagen-induced arthritis by suppressing both inflammatory and Th17 cell responses. Int Immunopharmacol 2016;39:236-45. [PMID: 27494687 DOI: 10.1016/j.intimp.2016.07.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]